ObsEva

$1.88
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.16 (-7.80%) Today
-$0.01 (-0.53%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ObsEva and other stocks, options, and ETFs commission-free!

About OBSV

ObsEva SA engages in the research and development of therapeutic treatments for woman's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. Read More The company was founded by Ernest Loumaye and André Chollet in November 2012 and is headquartered in Geneva, Switzerland. The listed name for OBSV is ObsEva SA Ordinary Shares.

CEO
Ernest Loumaye
Employees
50
Headquarters
Geneva, Geneve (Geneva)
Founded
2012
Market Cap
105.68M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
479.32K
High Today
$2.02
Low Today
$1.86
Open Price
$2.02
Volume
1.17M
52 Week High
$8.50
52 Week Low
$1.63

Collections

OBSV Earnings

-$0.80
-$0.53
-$0.27
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 13, Pre-Market

You May Also Like